Earnings estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 1 | 1 | 2 | 3 |
Avg. Estimate | -0.02 | -0.02 | -0.07 | -0.08 |
Low estimate | -0.02 | -0.02 | -0.07 | -0.09 |
High estimate | -0.02 | -0.02 | -0.07 | -0.08 |
Year ago EPS | -0.08 | -0.1 | -0.13 | -0.07 |
Revenue estimate | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 1 | 1 | 2 | 3 |
Avg. Estimate | N/A | N/A | N/A | N/A |
Low estimate | N/A | N/A | N/A | N/A |
High estimate | N/A | N/A | N/A | N/A |
Year ago sales | N/A | N/A | 354k | N/A |
Sales growth (year/est) | N/A | N/A | N/A | N/A |
Earnings history | 30/09/2022 | 31/12/2022 | 30/09/2023 | 31/12/2023 |
---|---|---|---|---|
Est. EPS | -0.09 | -0.1 | -0.02 | -0.01 |
Actual EPS | -0.08 | -0.1 | -0.01 | -0.02 |
Difference | 0.01 | 0 | 0.01 | -0.01 |
Surprise % | 11.10% | 0.00% | 50.00% | -100.00% |
EPS trend | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Current estimate | -0.02 | -0.02 | -0.07 | -0.08 |
7 days ago | -0.02 | -0.02 | -0.07 | -0.08 |
30 days ago | -0.02 | -0.02 | -0.07 | -0.08 |
60 days ago | -0.02 | -0.02 | -0.07 | -0.08 |
90 days ago | 0 | 0 | -0.07 | -0.08 |
EPS revisions | Current qtr. (Mar 2024) | Next qtr. (Jun 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | BGBIO.OL | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | 75.00% | N/A | N/A | N/A |
Next qtr. | 80.00% | N/A | N/A | N/A |
Current year | 46.20% | N/A | N/A | N/A |
Next year | -14.30% | N/A | N/A | N/A |
Next 5 years (per annum) | N/A | N/A | N/A | N/A |
Past 5 years (per annum) | N/A | N/A | N/A | N/A |